Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Catherine C. Coombs"'
Autor:
Steven M. Johnson, James Haberberger, Jonathan Galeotti, Lori Ramkissoon, Catherine C. Coombs, Daniel R. Richardson, Matthew C. Foster, Daniel Duncan, Joshua F. Zeidner, Naomi L. Ferguson, Nathan D. Montgomery
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/0205bf92f623489f8f3ab8c60ddb2fb6
Autor:
Wojciech Jurczak, Catherine C. Coombs, Nirav N. Shah, Jennifer Woyach, Chan Y. Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Catherine E. Muehlenbein, Chunxiao Wang, Sarang Abhyankar, Donald E. Tsai, Toby A. Eyre
Publikováno v:
HemaSphere, Vol 7, p e6206253 (2023)
Externí odkaz:
https://doaj.org/article/40198fe5ff264234844ad625358f4e4b
Autor:
Frederick Lansigan, Toby A. Eyre, Nilanjan Ghosh, Beenish S. Manzoor, Catherine C. Coombs, Nicole Lamanna, Hande H. Tuncer, Dozie Emechebe, Jennifer R. Brown, Lindsey E. Roeker, Chaitra Ujjani, Hasan Alhasani, Isabelle Fleury, Lori A. Leslie, Alan Skarbnik, Joanna Rhodes, Brian T. Hill, Paul M. Barr, Matthew S. Davids, Christopher P. Fox, Yun Choi, Anna Schuh, Kaitlin Kennard, Christopher E. Jensen, Dureshahwar Jawaid, Aditya Sharma, Irina Pivneva, Talissa Watson, Mazyar Shadman
Publikováno v:
HemaSphere, Vol 7, p e6855326 (2023)
Externí odkaz:
https://doaj.org/article/d6ea9ee9d0d646edb5abcb1d76ec0b76
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Bruton’s tyrosine kinase (BTK) is a critical downstream signaling element from the B-cell receptor (BCR) that has been effectively inhibited in B-cell cancers by irreversible, covalent inhibitors including ibrutinib and acalabrutinib. All FDA-appro
Externí odkaz:
https://doaj.org/article/d7584c9dcf514828b2e891b6b8358d6c
Publikováno v:
Cancers, Vol 15, Iss 6, p 1838 (2023)
Cellular therapies can be viewed as both the newest and oldest techniques for treating chronic lymphocytic leukemia (CLL) and Richter’s transformation (RT). On one hand, allogeneic hematopoietic stem cell transplantation (alloHSCT) has been availab
Externí odkaz:
https://doaj.org/article/17303225a2ba407a9022a9c4835e59bf
Autor:
Christopher Trennepohl, Jonathan Sorah, Patrick Eulitt, Jonathan Galeotti, Joshua F. Zeidner, Nathan D. Montgomery, Catherine C. Coombs
Publikováno v:
Clinical Case Reports, Vol 7, Iss 11, Pp 2274-2276 (2019)
Abstract Immunophenotyping is critical to the diagnosis of MS, as it can be difficult to differentiate from other diagnoses including lymphoma using conventional light microscopy.
Externí odkaz:
https://doaj.org/article/f3f7fa242a514b4a8696e1255db81ccc
Autor:
Julia W. Sheets, Patrick Eulitt, Rong He, Horatiu Olteanu, Catherine C. Coombs, Matthew C. Foster, Nathan D. Montgomery, Joshua F. Zeidner
Publikováno v:
HemaSphere, Vol 4, Iss 6, p e484 (2020)
Externí odkaz:
https://doaj.org/article/5402f71d711344099f6bfde611458812
Autor:
Toby A. Eyre, Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, Bruce D. Cheson, Maryam Yazdy, John N. Allan, Joanna Rhodes, Stephen J. Schuster, Chadi Nabhan, Alan Skarbnik, Lori Leslie, Prioty Islam, Katherine Whitaker, Catherine C. Coombs, Hande H. Tuncer, John M. Pagel, Ryan Jacobs, Allison M. Winter, Neil Bailey, Andrea Sitlinger, Anna H. Schuh, George Follows, Christopher P. Fox, Danielle M. Brander, Mazyar Shadman, Anthony R. Mato
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/ad08843e37b24e96ad4960bf18e8f92a
Autor:
Steven M. Johnson, Daniel R. Richardson, Jonathan Galeotti, Sonia Esparza, Anqi Zhu, Yuri Fedoriw, Karen E. Weck, Matthew C. Foster, Catherine C. Coombs, Joshua F. Zeidner, Nathan D. Montgomery
Publikováno v:
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/551ed8b5d9a34c68970a760ebccaa016
Autor:
Matthieu Duchmann, Fevzi F. Yalniz, Alessandro Sanna, David Sallman, Catherine C. Coombs, Aline Renneville, Olivier Kosmider, Thorsten Braun, Uwe Platzbecker, Lise Willems, Lionel Adès, Michaela Fontenay, Raajit Rampal, Eric Padron, Nathalie Droin, Claude Preudhomme, Valeria Santini, Mrinal M. Patnaik, Pierre Fenaux, Eric Solary, Raphael Itzykson
Publikováno v:
EBioMedicine, Vol 31, Iss , Pp 174-181 (2018)
Somatic mutations contribute to the heterogeneous prognosis of chronic myelomonocytic leukemia (CMML). Hypomethylating agents (HMAs) are active in CMML, but analyses of small series failed to identify mutations predicting response or survival. We ana
Externí odkaz:
https://doaj.org/article/475ef9172ad444098b8af25c6b442881